/
© 2026 RiffOn. All rights reserved.

Get your free personalized podcast brief

We scan new podcasts and send you the top 5 insights daily.

  1. Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders
  2. 251: Why a Single Large DoE Fails Biosimilar Glycan Optimization — And the Parallel Screening Method That Actually Works
251: Why a Single Large DoE Fails Biosimilar Glycan Optimization — And the Parallel Screening Method That Actually Works

251: Why a Single Large DoE Fails Biosimilar Glycan Optimization — And the Parallel Screening Method That Actually Works

Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders · May 12, 2026

Ditch single large DoEs for biosimilar glycan optimization. A parallel screening method delivers superior results in just two experimental rounds.

Include "Anchor Compounds" in Parallel Experiments for Cross-Group Calibration

When running multiple independent but parallel experiments, include well-characterized compounds in every group. These "anchor compounds" serve as internal calibration references, creating a baseline that allows for robust and reliable comparison of results across the otherwise separate experimental sets.

251: Why a Single Large DoE Fails Biosimilar Glycan Optimization — And the Parallel Screening Method That Actually Works thumbnail

251: Why a Single Large DoE Fails Biosimilar Glycan Optimization — And the Parallel Screening Method That Actually Works

Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders·2 days ago

Use Mahalanobis Distance to Quantify Glycan Profile Similarity to a Reference Product

To optimize a complex biosimilar profile with many correlated attributes like glycoforms, use Mahalanobis distance. It calculates a single multivariate distance to the target profile, correctly accounting for inter-glycoform correlations, providing an objective, data-driven method for ranking experimental outcomes.

251: Why a Single Large DoE Fails Biosimilar Glycan Optimization — And the Parallel Screening Method That Actually Works thumbnail

251: Why a Single Large DoE Fails Biosimilar Glycan Optimization — And the Parallel Screening Method That Actually Works

Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders·2 days ago

Parallel Grouped Experiments Outperform Single, Large-Scale Bioprocess DOEs

Instead of one massive experiment, split numerous factors into smaller, biologically-themed groups. Running these focused experiments in parallel is superior to both one-factor-at-a-time and large DOE approaches, as it maintains the breadth of a large screen while providing the high-quality signal of a small one.

251: Why a Single Large DoE Fails Biosimilar Glycan Optimization — And the Parallel Screening Method That Actually Works thumbnail

251: Why a Single Large DoE Fails Biosimilar Glycan Optimization — And the Parallel Screening Method That Actually Works

Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders·2 days ago

Large-Scale DOE in Bioprocessing Fails Due to Dilution, Toxicity, and Masking Effects

A single, massive Design of Experiments (DOE) for screening many compounds is flawed. Adding numerous stock solutions causes dilution, untested combinations can be toxic to cells, and the strong effect of one compound can mask the subtler, yet crucial, effects of others, leading to poor data quality.

251: Why a Single Large DoE Fails Biosimilar Glycan Optimization — And the Parallel Screening Method That Actually Works thumbnail

251: Why a Single Large DoE Fails Biosimilar Glycan Optimization — And the Parallel Screening Method That Actually Works

Smart Biotech Scientist | The CMC and Bioprocessing Podcast for Process Development and Manufacturing Leaders·2 days ago